Brief: Establishment Labs Q2 Loss Per Share $0.35
Aug 14 (Reuters) - Establishment Labs Holdings Inc ESTA.O :
* ESTABLISHMENT LABS REPORTS SECOND QUARTER 2018 FINANCIAL
RESULTS
* Q2 REVENUE ROSE 59 PERCENT TO $13.7 MILLION
* REMAINED ON TRACK FOR U.S. FOOD AND DRUG ADMINISTRATION
(FDA)
CLINICAL TRIAL
* QTRLY LOSS PER SHARE $0.35
* CASH BALANCE AS OF JUNE 30, 2018 WAS $11.6 MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nGNX6JnxmW
Further company coverage: ESTA.O
(((Reuters.Briefs@thomsonreuters.com);))
Recent news on Establishment Labs Holdings
See all newsU.S. STOCKS ON THE MOVE-Nike, Synopsys, Intel
U.S. STOCKS ON THE MOVE- Cenovus Energy, TeraWulf, Alector
Establishment Labs gains on US FDA approval for more Motiva implant sizes
Brief: Establishment Labs Receives FDA Approval For Additional Sizes Of Motiva Implants
U.S. STOCKS ON THE MOVE-FuelCell, Gold miners, NetApp